the rare disease drug dilemma: great value, high price, limited access?
Published 4 years ago • 971 plays • Length 1:04:54Download video MP4
Download video MP3
Similar videos
-
46:42
the scary future of rare disease management
-
36:07
innovative solutions for fast tracking drugs for rare diseases
-
2:07
fda approves world’s most expensive drug to treat rare disease | nbc nightly news
-
1:03
the tools you need to accelerate rare disease drug development
-
1:01:48
why pharmaceuticals are so complicated in the u.s. | cnbc marathon
-
12:24
world's most expensive drug costs $2,500,000 – doctor explains
-
13:28
patient centricity - the next big differentiator in pharma marketing
-
4:17
certara talks - rare disease day 2024
-
9:25
certara talks - rare disease day 2024 regulatory landscape
-
2:00
rare disease drugs and market implications
-
6:16
certara talks - rare disease day 2024 clinical pharmacology
-
5:53
the orphan drug act and rare disease drug pricing
-
1:00:08
expanded access for rare diseases
-
31:48
panel discussion: the high cost of rare diseases
-
1:41
rare disease drug development and patient centricity
-
12:54
rare diseases cost 3 to 5 times more than common diseases
-
1:42
the promises and pitfalls of gene therapy for rare diseases: recent setbacks in gene therapy
-
3:26
orphacodes for rare diseases
-
17:43
2022 nhpdd day 1, session 2, part 1
-
6:36
rare disease trials: the beginning, the middle and the end
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development